OBJECTIVES: To investigate whether (a) variants within the dopamine D2 receptor gene (DRD2) are associated with obesity and type 2 diabetes in Pima Indians, and (b) whether variation in this gene could be responsible for previously observed linkage to these phenotypes, at chromosome location 11q23 ± 24, in this population. DESIGN: Two single nucleotide polymorphisms (SNPs), Ser311Cys and TaqIA, within the DRD2 gene were genotyped by allelic discrimination PCR in subjects who had provided evidence of linkage to diabetes and obesity in an autosome-wide scan. SUBJECTS: A total of 1187 subjects were genotyped, including 947 full heritage Pima Indians (80%). Descriptive statistics for all subjects analyzed, for whom clinical data were available, were (mean AE s.d.): age at time of last exam 41 AE 15 y; birth year 1950 AE 14; age-sex-adjusted body mass index (BMI; adjusted to a mean age of 35 y) 36 AE 8 kgam 2 ; male 44%; diabetic 57%. For full heritage Pimas only: age 43 AE 15 y; birth year 1948 AE 14; sex ± age-adjusted BMI 36 AE 8 kgam 2 ; male 43%; diabetic 59%. RESULTS: Neither polymorphism was signi®cantly associated with diabetes in full heritage Pimas. Individuals with à CG' genotype at the Ser311Cys SNP had a higher BMI than those with a`CC' genotype (36.7 vs 35.5 kgam 2 , P 0.04). Linkage analysis of BMI, adjusted for either polymorphism, resulted in LOD scores that were similar to those obtained without adjustment. CONCLUSION: Heterozygotes at the Ser311Cys DRD2 polymorphism had a slightly higher BMI than homozygotes, however neither the Ser311Cys nor the TaqIA polymorphism accounted for the linkage with BMI on chromosome 11 in Pima Indians.
Introduction
The dopamine D2 receptor (DRD2), is a G-coupled receptor expressed in the CNS which inhibits adenylyl cyclase, thereby down-regulating cAMP. The DRD2 gene has been mapped to a locus on human chromosome 11q23, adjacent to the gene for the neural cell adhesion molecule, NCAM, and the apolipoprotein AI-CIII-AIV gene cluster, all of which have potential involvement in human obesity andaor diabetes. 1 ± 4 Several lines of evidence support an involvement of DRD2 in appetite regulation. Various drugs that are known to interact with the DRD2 receptor have ingestive side effects in addition to their central neuroleptic effects. Dopaminergic agonists such as dextroamphetamine and bromocriptine are powerful suppressors of appetite and weight gain, whereas antagonists, such as haloperidol, enhance appetite. 5, 6 The anti-obesity drugs fen¯uramineadexfen¯uramine and phentermine may also act, at least indirectly, through the DRD2 receptor. 7, 8 Consistent with such a role, dopamine transporter mRNA was found to be increased in the CNS of Zucker faafa rats. 9 A role for dopamine in the regulation of feeding pattern during obesity was also supported by behavioral changes following grafting of embryonic dopaminergic neurons into the brains of Zucker rats. 10 Genetic studies in human populations have shown an association of DRD2 with obesity. Such associations may also be indicative of an involvement in type 2 diabetes mellitus since obesity is a major risk factor for the disease. 11 In an investigation of 484 mostly Caucasian subjects, a signi®cant difference in weight with DRD2 haplotype was found, indicating that a particular DRD2 genotype may be a risk factor for type 2 diabetes. 12 DRD2 genotype was also associated with obesity phenotypes in a different study of 73 mostly Caucasian subjects. 13 In a study of adult nonHispanic Caucasians, an association between body mass index (BMI) and leptinaDRD2 variants was also reported. 14 A preliminary report described an increased prevalence of a DRD2 variant in obesity with comorbid substance abuse disorder, with a signi®cant increased risk for obesity and other related addictive behaviors. 15 In an autosomal genomic scan for linkage of genetic markers to type 2 diabetes and obesity in Pima Indians, the strongest evidence for linkage with BMI was found at chromosome 11q23 ± 24. Multipoint logarithm of the odds (LOD) estimates at this locus, for diabetes, BMI, and a bivariate phenotype, were, respectively, 1.7, 3.6 and 5.3. 16 These results are consistent with those from independent studies in other human populations and in a polygenic rat model of type 2 diabetes and obesity. 17 ± 21 DRD2 is located approximately 15 cm from the location of the maximum LOD score. Given the variation in location estimates in linkage studies of complex traits 22, 23 and previously observed association of DRD2 polymorphisms with obesity, it is plausible that these polymorphisms may account for linkage of BMI with chromosome 11q in Pima Indians.
The purpose of our study was to determine whether variation in DRD2 could be responsible for the linkage at 11q23 to diabetes and obesity in Pima Indians. We therefore screened two markers within the DRD2 gene, Ser311Cys and TaqIA, in a set of 1187 subjects (including 947 full heritage Pimas) who had participated in a genome-wide scan for loci linked to diabetes and obesity. 16 Ser311Cys is a functional mutation within the DRD2 coding sequence, a C to G transversion that leads to a missense amino acid substitution of cysteine for serine at amino acid position 311 of the receptor. 24 This amino acid change occurs in the third intracellular loop and has been shown to substantially impair downstream signal transduction from the DRD2 receptor in cultured mammalian cells (CHO-K1), apparently via reduced activation of the appropriate G-protein which in turn leads to decreased inhibition of cAMP production. 25 TaqIA is a T to C transition in the 3 H non-coding region of the gene, 10.5 kb downstream of the stop codon and 9.4 kb downstream of the polyA signal. It was used in the earlier studies of association of DRD2 with obesity.
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Methods
Subjects
Subjects for the present analysis were selected from among participants in a genome-wide linkage study for loci in¯uencing obesity and type 2 diabetes mellitus. 16 This linkage study included 1338 individuals from 332 nuclear families. Phenotypic characteristics of these individuals were assessed as part of a longitudinal epidemiological study in which community residents were invited to have a health examination every 2 y. 26 Height and weight were measured with the subject wearing light clothing and no shoes and were used to calculate BMI (kgam 2 ). Because BMI in children may have a different interpretation than in adults, BMI data in the present analysis were only used for persons !15 y of age. A 75 g oral glucose tolerance test was administered and diabetes diagnosed if the 2 h post-load plasma glucose was !11.1 mM 27 or if the diagnosis was made during the course of routine clinical care. The extent to which an individual's heritage was from American Indian or other sources was assessed by self-report, as previously described. 28 In the present study, all individuals from the linkage study who had suf®cient DNA available (n 1259) were selected for genotyping of the two DRD2 polymorphisms. At least one of these polymorphisms could be typed in 1187 individuals (1185 were typed for Ser311Cys; 1175 were typed for TaqIA, and 1173 were typed for both polymorphisms). To minimize confounding by population strati®cation, some analyses were restricted to the 947 individuals whose heritage was full Pima, Tohono O'odham or a mixture of these two closely related tribes. The study was approved by the Institutional Review Board of the National Institutes of Diabetes and Digestive and Kidney Diseases and the Tribal Council of the Gila River Indian Community, and subjects gave informed consent.
Genotyping
Single nucleotide polymorphisms (SNPs) were genotyped by Taqman 1 allelic discrimination polymerase chain reaction (PCR) 29 ,30 using a model 7700 ABI Prism instrument (PE Applied Biosystems, Foster City, California). For the Ser311Cys SNP, two double-probe sets were used, at equal concentrations, to suppress a rare second His313His silent SNP present just seven nucleotides downstream. Four probes were required, with only two reporter dyes, in order to give only two possible¯uorescent signals for the two Ser311Cys variants. We chose not to type the second variant because it was present at low frequency and therefore not as statistically useful as the Ser311Cys variant, given our sample size. In some cases SNPs were independently con®rmed by direct DNA sequencing.
Statistical analysis
Prior to statistical analyses the natural logarithm of the maximum BMI observed during the longitudinal study was adjusted for age and sex (using data from the entire population) by linear regression and subsequent analyses were conducted using the resultant`residuals'. For presentation purposes, the value for age 35 predicted by the regression equation was added to the residual and the antilogarithm was taken to obtain an`age ± sex-adjusted' BMI value. The association of genotypes for these DRD2 polymorphisms with BMI and prevalence of diabetes was analyzed using generalized estimating equations 31 which account for the dependence introduced by studying nuclear families. A linear model was used for BMI and a binomial (logistic) model was used for diabetes; all analyses included covariates for age, sex and birth year. Statistical signi®cance was determined using the Wald statistic. 32 Linkage disequilibrium between the TaqIA and Ser311Cys loci was assessed using a chi-square test.
To determine the extent to which these polymorphisms might account for the linkage of BMI to chromosome 11 observed in these pedigrees, results of linkage analyses conducted with adjustment for the DRD2 genotypes were compared with results of analyses that ignored the effects of these genotypes. Variance components methods were used to assess the evidence for linkage. 33 In brief, this method involves ®tting a linear`mixed' model in which the trait mean is in¯u-enced by a number of ®xed effects and the variance is partitioned into three components: a polygenic component which depends on the familial relationships between individuals; an environmental component which re¯ects effects unique to the individual; and a monogenic component which depends on the proportion of alleles shared identical by descent, estimated from the marker data. Multipoint estimates of the proportion of alleles identical by descent at chromosomal locations were calculated in 1 cm intervals by the method of Fulker et al. 34 The evidence for linkage, presented as a LOD score, was assessed by the likelihood ratio test comparing the model in which the monogenic component was estimated to one in which this component was ®xed at 0. The effect of the DRD2 polymorphisms on the linkage signal was evaluated by comparison of the LOD score determined from a model which included the DRD2 genotypes as ®xed effects with the LOD score derived from a model which did not include these genotypes. Simulation studies have shown that this approach will diminish the strength of the linkage signal in proportion to the degree of linkage disequilibrium between the polymorphism in question and that responsible for the linkage Ð if the polymorphism analyzed is the one responsible for the linkage, the expected LOD score is 0. 35 
Results
The SNPs were in Hardy-Weinberg equilibrium, and in strong linkage disequilibrium (P`0.001) despite being separated by 12.5 kb. Table 1 shows the prevalence of diabetes and mean BMI by genotype for all individuals. Analyses are shown for all three genotypes at each SNP and for combined genotypes at both SNPs. There was an association of age with the TaqIA genotype, with the youngest age group having a lower prevalence of the T allele (P 0.031, 8 d.f.) There was a tendency for those who were heterozygous at the Ser311Cys SNP to have the highest BMI among the full-heritage Pimas.
Association analyses of BMI in full-heritage Pima Indians are shown in Table 2 , controlling for age, sex, birth year and nuclear family membership. The individuals with the`CG' genotype at the Ser311Cys polymorphism had a signi®cantly higher BMI than those with the`CC' genotype (36.7 vs 35.5 kgam 2 , P 0.04), but the more rigorous test of the overall null hypothesis that all three means are equal was not statistically signi®cant (P 0.08, 2 d.f.). There did not BMI is the age-and sex-adjusted residual of the log of the maximal BMI observed after age 15. It is transformed to be adjusted to a mean age of 35 y. 
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CP Jenkinson et al appear to be any effect of the TaqIA polymorphism on BMI, and combinations of Ser311Cys and TaqIA did not produce any substantial differences. Table 3 shows the association analyses of diabetes, adjusted for age, sex, birth year and nuclear family membership in full-heritage Pima Indians. There were no substantial differences in diabetes prevalence among the genotypes for either Ser311Cys or TaqIA, or for combinations of the two. Figure 1 shows the results of the chromosome 11 multipoint linkage analyses for BMI in all subjects, unadjusted and adjusted for the TaqIA and Ser311Cys SNPs. These analyses were calculated for most of the sibships in the previously described genomic scan 16 and no restriction was made on the heritage of individuals. Adjustment for these polymorphisms did not have a substantial impact on the linkage results.
Discussion
An autosomal genome-wide linkage study in Pima Indians identi®ed a locus in¯uencing diabetes and obesity on chromosome 11q23 ± 24. 16 Since the peak of linkage was located near the DRD2 locus, a plausible candidate gene for obesity, the present study investigated the association of two important DRD2 polymorphisms, TaqIA and Ser311Cys, with diabetes and obesity in Pimas who had participated in the genome-wide linkage study. Neither polymorphism was associated with diabetes. Persons who were heterozygous for the Ser311Cys polymorphism had a slightly higher BMI (on average 1.2 kgam 2 ) than homozygous individuals. However, adjustment for the effect of this polymorphism had little impact on the evidence for linkage with BMI in the 11q23 ± 24 region. This suggests that the modest association of Ser311Cys with BMI cannot be responsible for the linkage signal in this region, and an alternative explanation must be sought.
The TaqIA polymorphism has been equivocally associated with a number of behavioral traits including alcoholism 36 and obesity. 12 ± 15 These earlier association studies were performed in samples drawn from genetically heterogeneous populations, and were therefore subject to the possibility of the confounding effect of admixture. Spurious associations of genotype with disease phenotype may occur in studies of admixed populations when the frequency of an allele varies signi®cantly with the extent of genetic admixture. 37 In contrast, the present association study was con®ned to full-heritage Pima Indians, a relatively genetically homogeneous population which might therefore be expected to exhibit a strong founder effect, with a concomitantly small number of disease-causing alleles, and linkage disequilibrium extending over larger genomic distances. 38 The biological signi®cance of the modest association of heterozygosity at Ser311Cys with higher BMI is unclear. It is possible that the Ser311Cys polymorphism per se, acting by an as yet undetermined physiological mechanism, represents a minor obesity gene in the Pimas. It is also possible that this polymorphism is in weak linkage disequilibrium with a causative polymorphism at the putative major obesity 
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CP Jenkinson et al locus inferred from the genome-wide linkage study. Although we sought to minimize population strati®ca-tion by restricting the analysis to full-heritage Pimas, we cannot exclude the possibility that the higher BMI observed in persons heterozygous for Ser311Cys is due to undetected strati®cation or to chance. Since the Ser311Cys SNP did not account for the linkage to BMI observed in this region, in contrast to a priori expectations, the statistical evidence for association must be regarded as tentative. In summary, there may be a weak effect of heterozygosity at the Ser311Cys polymorphism on BMI; however, this effect is much too weak to explain the linkage result. Thus these DRD2 polymorphisms are not responsible for the linkage of BMI to chromosome 11q in Pima Indians.
